Key result
Successful reperfusion with mTICI 3 following mechanical thrombectomy was associated with higher 3-month functional independence compared to mTICI 2b (55% vs 44%; OR 2.08, 95% CI 1.22-3.53).
Why the study?
Does achieving mTICI 3 reperfusion improve functional outcomes and safety compared to mTICI 2b reperfusion in acute ischemic stroke patients treated with mechanical thrombectomy?
Cohort (n=416)
Yes
Does achieving mTICI 3 reperfusion improve functional outcomes and safety compared to mTICI 2b reperfusion in acute ischemic stroke patients treated with mechanical thrombectomy?
Odds Ratio: 2.08 (95% CI 1.22–3.53)
Absolute Event Rate: 55% vs 44%
p-value: p=<.05
Achieving complete reperfusion (mTICI 3) during mechanical thrombectomy for acute ischemic stroke yields significantly better neurological and functional outcomes with fewer hemorrhagic complications than near-complete reperfusion (mTICI 2b).
May support targeting mTICI 3 over 2b; hypothesis-generating pending randomized confirmation.
BACKGROUND: Mechanical thrombectomy (MT) is the current standard of care for acute ischemic stroke (AIS) patients with emergent large-vessel occlusions (ELVO). Successful reperfusion of ELVO is traditionally defined by modified Thrombolysis in Cerebral Infarction (mTICI) grades of 2b or 3. OBJECTIVE: To evaluate the comparative safety and efficacy of mTICI 2b and mTICI 3 reperfusion in AIS patients treated with MT. METHODS: Consecutive ELVO patients who underwent MT at 6 high-volume centers were included in this analysis. Standard safety (3-mo mortality, symptomatic intracranial hemorrhage [sICH]) and efficacy (absolute and relative reduction in NIHSS-scores during hospitalization, functional-improvement [shift analysis in mRS-scores], and functional-independence [mRS-scores of 0-2] at 3-mo) were compared between patients who had mTICI 2b and mTICI 3 reperfusion post MT. RESULTS: A total of 416 ELVO patients achieved successful reperfusion with mTICI 2b (n = 216) and mTICI 3 (n = 200) following MT. The mTICI 3 group had significantly (P < .05) greater absolute (11 vs 9 points) and relative (77% vs 63%) reduction in NIHSS-scores during hospitalization, lower sICH (6% vs 12%), and higher 3-mo functional-independence (55% vs 44%) rates. Successful reperfusion with mTICI 3 was independently (P < .05) associated with greater absolute and relative reduction in NIHSS-scores during hospitalization as well as higher odds of 3-mo functional improvement (common odds ratios: 1.67; 95% confidence interval: 1.10-2.56) and functional independence (odds ratio: 2.08; 95% confidence interval: 1.22-3.53) in multivariable regression models adjusting for confounders. CONCLUSION: Successful reperfusion with mTICI 3 was associated with greater neurological improvement during hospitalization and better 3-mo functional outcomes in comparison to mTICI 2b reperfusion.
No takes yet. Share an insight, caveat, or question.
Goyal et al. (2018) conducted a cohort in Acute ischemic stroke with emergent large-vessel occlusions (n=416). mTICI 3 reperfusion vs. mTICI 2b reperfusion was evaluated on 3-month functional independence (mRS scores of 0-2) (OR 2.08, 95% CI 1.22-3.53, p=<.05). Successful reperfusion with mTICI 3 following mechanical thrombectomy was associated with higher 3-month functional independence compared to mTICI 2b (55% vs 44%; OR 2.08, 95% CI 1.22-3.53).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: